Edward M. Wolin, MD (Medical Oncology)Director of the Center for Carcinoid and Neuroendocrine Tumors
Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Center for Carcinoid and Neuroendocrine Tumors
The Mount Sinai Hospital
One Gustave L. Levy Place, Box 1041
New York, NY 10029
Tel: 212-241-6756 (New Patient Appointments)
Tel: 212-241-5466 (The Center for Carcinoid and Neuroendocrine Tumors)
As Director of the Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai, Dr. Wolin brings a robust research program to Mount Sinai, including multiple clinical trials. His research efforts focus on finding treatments which are more effective and less toxic, including pasireotide, lanreotide, everolimus, other m-TOR inhibitors, targeted radiation including peptide receptor radiotherapy with Lu-177, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, and targeted treatment of liver metastases. Dr. Wolin’s research is also directed at development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.
Dr. Wolin also serves as Co-Medical Director of the Carcinoid Cancer Foundation.
Meet Dr. Wolin: